bf/NASDAQ:ADMA_icon.jpeg

COM:ADMABIOLOGICS

ADMA Biologics, Inc.

  • Stock

Last Close

21.37

21/11 21:00

Market Cap

5.04B

Beta: -

Volume Today

2.00M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.47M
-
1.69M
15.10%
2.58M
52.60%
4.23M
64.24%
8.82M
108.46%
15.62M
77.04%
35.84M
129.42%
67.30M
87.78%
103.13M
53.24%
144.00M
39.63%
168.09M
16.73%
average payables
1.88M
-
2.24M
19.12%
1.93M
13.85%
2.33M
20.31%
4.24M
82.39%
5.91M
39.31%
7.54M
27.52%
10.12M
34.32%
11.75M
16.07%
12.83M
9.17%
14.44M
12.59%
average receivables
19.56K
-
191.98K
881.70%
654.21K
240.77%
971.25K
48.46%
2.45M
152.16%
2.64M
7.64%
2.43M
7.78%
8.35M
243.60%
20.91M
150.28%
22.04M
5.42%
21.46M
2.62%
book value per share
3.30
-
0.65
80.42%
0.08
87.81%
-0.37
565.14%
1.76
580.32%
0.44
75.16%
0.48
10.16%
1.02
112.56%
1.01
1.27%
0.77
24.06%
0.00
99.92%
capex per share
-0.03
-
-0.25
730.45%
-0.00
99.00%
-0.01
141.22%
-0.12
1,835.18%
-0.05
60.33%
-0.07
51.24%
-0.15
110.64%
-0.10
34.48%
-0.07
27.37%
-0.00
99.97%
capex to depreciation
-0.93
-
-9.37
904.08%
-0.06
99.41%
-0.16
181.70%
-0.99
535.87%
-0.61
38.83%
-1.17
92.41%
-3.23
175.93%
-2.46
23.84%
-1.96
20.46%
-0.57
70.72%
capex to operating cash flow
0.02
-
0.16
774.76%
0.00
98.93%
0.00
137.62%
0.07
1,686.97%
0.03
53.44%
0.05
49.63%
0.12
149.39%
0.12
3.63%
0.23
94.42%
-0.54
331.92%
capex to revenue
-0.06
-
-0.39
512.68%
-0.00
99.08%
-0.01
89.56%
-0.12
1,607.66%
-0.12
4.93%
-0.13
5.27%
-0.30
132.09%
-0.17
44.62%
-0.09
45.91%
-0.02
79.54%
cash per share
4.45
-
2.35
47.19%
1.61
31.35%
1.26
21.99%
1.88
49.51%
0.50
73.25%
0.49
2.25%
0.65
31.88%
0.37
43.61%
0.44
19.46%
0.00
99.95%
days of inventory on hand
301.07
-
166.66
44.65%
291.71
75.04%
288.07
1.25%
158.05
45.14%
161.04
1.89%
490.29
204.46%
485.56
0.97%
570.70
17.53%
501.60
12.11%
372.83
25.67%
days payables outstanding
488.75
-
173.53
64.50%
176.75
1.86%
147.17
16.74%
74.10
49.65%
51.04
31.12%
84.77
66.08%
65.95
22.21%
56.87
13.76%
40.64
28.54%
33.77
16.91%
days sales outstanding
23.69
-
47.01
98.44%
34.85
25.86%
62.22
78.53%
29.92
51.91%
43.15
44.22%
114.44
165.19%
128.86
12.60%
36.73
71.50%
38.76
5.53%
debt to assets
0.16
-
0.55
246.42%
0.66
20.65%
0.86
28.95%
0.43
49.90%
0.50
16.12%
0.67
33.98%
0.47
29.46%
0.37
20.78%
0.44
18.97%
0.43
3.07%
debt to equity
0.24
-
2.49
958.95%
19.16
669.08%
-4.55
123.72%
1.15
125.25%
2.24
94.90%
3.23
44.61%
1.11
65.79%
0.73
34.13%
1.02
39.40%
1.05
2.92%
dividend yield
earnings yield
-0.30
-
-0.16
46.85%
-0.21
32.02%
-0.31
46.65%
-0.60
89.84%
-0.61
2.24%
-0.26
56.89%
-0.52
98.74%
-0.43
17.72%
-0.11
74.14%
-0.00
99.97%
enterprise value
29.87M
-
101.56M
240.03%
89.32M
12.06%
72.57M
18.75%
73.36M
1.09%
129.47M
76.49%
275.37M
112.69%
209.73M
23.84%
248.64M
18.55%
835.68M
236.10%
1.01T
121,055.56%
enterprise value over ebitda
-2.03
-
-6.32
211.76%
-5.95
5.77%
-4.32
27.45%
-1.97
54.31%
-2.28
15.59%
-6.88
201.84%
-3.27
52.42%
-4.30
31.18%
-21.30
395.73%
46.80K
219,869.66%
ev to operating cash flow
-2.74
-
-6.91
151.75%
-5.79
16.13%
-3.97
31.43%
-1.97
50.45%
-2.07
4.95%
-3.61
74.96%
-2.06
43.11%
-2.21
7.61%
-14.04
534.66%
115.05K
819,390.48%
ev to sales
9.74
-
17.17
76.33%
12.44
27.52%
6.81
45.30%
3.22
52.65%
7.62
136.50%
9.38
23.09%
4.97
47.06%
3.07
38.16%
5.42
76.57%
3.92K
72,194.84%
free cash flow per share
-1.70
-
-1.83
7.98%
-1.48
19.06%
-1.51
1.75%
-1.74
15.61%
-1.43
17.84%
-1.47
2.70%
-1.33
9.53%
-0.90
32.28%
-0.37
58.86%
0.00
100.00%
free cash flow yield
-0.22
-
-0.16
24.59%
-0.18
12.03%
-0.29
60.37%
-0.54
84.39%
-0.60
10.34%
-0.37
38.64%
-0.68
85.58%
-0.64
6.35%
-0.10
85.05%
0.00
100.00%
graham net net
2.99
-
0.19
93.61%
-0.35
284.40%
-0.79
123.37%
-0.67
14.78%
-0.80
18.79%
-0.83
3.96%
-0.15
82.05%
-0.00
99.05%
-0.08
5,898.46%
-0.00
99.81%
graham number
13.29
-
5.13
61.40%
1.75
65.90%
3.64
108.03%
8.70
139.10%
3.78
56.52%
3.37
10.85%
4.84
43.51%
3.71
23.36%
2.73
26.50%
0.00
99.95%
income quality
0.70
-
0.87
24.74%
0.86
1.90%
0.94
9.11%
0.85
9.01%
0.95
11.93%
1.58
65.53%
1.35
14.67%
1.57
16.47%
0.90
42.43%
-0.31
134.51%
intangibles to total assets
0
-
0
0
0
0.08
Infinity%
0.08
9.28%
0.05
37.91%
0.03
45.35%
0.02
33.83%
0.01
31.51%
0.01
6.12%
interest coverage
-24.33
-
-12.45
48.82%
-8.42
32.40%
-7.74
8.09%
-11.96
54.60%
-10.92
8.75%
-4.61
57.81%
-5.42
17.59%
-4.47
17.46%
-2.04
54.33%
-0.86
57.67%
interest debt per share
0.87
-
1.75
100.68%
1.69
3.53%
1.85
9.69%
2.17
16.96%
1.10
49.16%
1.72
56.65%
1.27
26.19%
0.83
34.72%
0.88
5.66%
0.00
99.94%
inventory turnover
1.21
-
2.19
80.65%
1.25
42.87%
1.27
1.26%
2.31
82.27%
2.27
1.86%
0.74
67.15%
0.75
0.98%
0.64
14.92%
0.73
13.78%
0.98
34.54%
invested capital
0.24
-
2.49
958.95%
19.16
669.08%
-4.55
123.72%
1.15
125.25%
2.24
94.90%
3.23
44.61%
1.11
65.79%
0.73
34.13%
1.02
39.40%
1.05
2.92%
market cap
50.94M
-
103.79M
103.74%
84.03M
19.04%
62.23M
25.95%
73.50M
18.11%
108.00M
46.95%
217.39M
101.29%
167.98M
22.73%
196.81M
17.16%
767.75M
290.11%
1.01T
131,762.12%
net current asset value
20.65M
-
2.87M
86.10%
-1.60M
155.87%
-6.49M
304.53%
-4.52M
30.31%
-24.58M
443.80%
-15.08M
38.65%
34.32M
327.61%
73.65M
114.62%
73.91M
0.36%
63.04M
14.72%
net debt to ebitda
1.43
-
0.14
90.30%
-0.35
354.27%
-0.62
74.61%
0.00
100.60%
-0.38
10,384.32%
-1.45
283.25%
-0.65
55.02%
-0.90
37.38%
-1.73
93.28%
4.16
340.54%
net income per share
-2.38
-
-1.81
23.89%
-1.73
4.62%
-1.61
6.96%
-1.91
19.02%
-1.45
23.88%
-1.05
27.85%
-1.02
3.11%
-0.61
40.50%
-0.43
28.85%
-0.00
99.97%
operating cash flow per share
-1.67
-
-1.58
5.06%
-1.48
6.43%
-1.50
1.51%
-1.63
8.29%
-1.39
14.79%
-1.40
1.08%
-1.18
15.54%
-0.81
32.01%
-0.30
62.64%
0.00
100.01%
payables turnover
0.75
-
2.10
181.66%
2.07
1.82%
2.48
20.10%
4.93
98.61%
7.15
45.18%
4.31
39.79%
5.53
28.54%
6.42
15.95%
8.98
39.94%
10.81
20.36%
receivables turnover
15.41
-
7.76
49.61%
10.47
34.88%
5.87
43.99%
12.20
107.95%
8.46
30.66%
3.19
62.29%
2.83
11.19%
9.94
250.84%
9.42
5.24%
research and ddevelopement to revenue
3.03
-
1.61
46.95%
0.98
39.24%
0.72
26.22%
0.27
62.05%
0.23
15.55%
0.08
65.45%
0.14
75.19%
0.05
67.80%
0.02
47.93%
0.01
45.51%
return on tangible assets
-0.49
-
-0.62
27.18%
-0.76
22.71%
-0.82
8.73%
-0.44
46.70%
-0.81
84.04%
-0.47
41.38%
-0.43
8.33%
-0.31
28.25%
-0.25
20.52%
-0.09
64.94%
revenue per share
0.47
-
0.64
35.54%
0.69
8.28%
0.88
27.25%
0.99
13.32%
0.38
62.19%
0.54
43.67%
0.49
9.24%
0.58
18.32%
0.78
34.28%
0.00
99.85%
roe
-0.72
-
-2.80
288.77%
-21.89
682.25%
4.38
120.00%
-1.08
124.78%
-3.33
206.50%
-2.18
34.51%
-0.99
54.42%
-0.60
39.74%
-0.56
6.30%
-0.21
62.74%
roic
-0.58
-
-0.74
26.98%
-1.06
44.11%
-1.22
14.56%
-0.50
58.91%
-1.02
103.60%
-0.44
57.24%
-0.39
9.51%
-0.27
30.71%
-0.16
41.37%
0.08
147.04%
sales general and administrative to revenue
1.42
-
0.82
42.70%
0.94
15.26%
0.80
15.22%
0.79
0.24%
1.32
66.66%
shareholders equity per share
3.30
-
0.65
80.42%
0.08
87.81%
-0.37
565.14%
1.76
580.32%
0.44
75.16%
0.48
10.16%
1.02
112.56%
1.01
1.27%
0.77
24.06%
0.00
99.92%
stock based compensation to revenue
0.29
-
0.21
27.12%
0.24
12.95%
0.12
50.81%
0.07
41.49%
0.13
90.77%
0.09
31.00%
0.07
25.13%
0.04
36.27%
0.03
21.47%
0.02
29.20%
tangible asset value
21.57M
-
6.01M
72.15%
820.97K
86.34%
-4.46M
642.92%
31.95M
816.90%
12.24M
61.71%
19.50M
59.39%
82.28M
321.84%
135.91M
65.19%
147.43M
8.47%
131.18M
11.02%
tangible book value per share
3.30
-
0.65
80.42%
0.08
87.81%
-0.37
565.14%
1.40
480.53%
0.27
80.60%
0.36
32.53%
0.96
166.13%
0.97
1.95%
0.75
23.48%
0.00
99.92%
working capital
27.39M
-
19.89M
27.39%
17.07M
14.16%
10.43M
38.89%
53.73M
414.90%
34.90M
35.03%
71.79M
105.68%
133.79M
86.36%
178.35M
33.30%
231.13M
29.60%
207.21M
10.35%

All numbers in (except ratios and percentages)